search
Back to results

Reliability of Paired Associative Stimulation-induced Neuroplasticity After Stroke (PASS)

Primary Purpose

Stroke

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
PAS true
PAS sham
Sponsored by
Burke Medical Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke

Eligibility Criteria

19 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Unilateral ischemic stroke with residual arm weakness (Fugl-Meyer Upper Limb < 60) more than 6 months prior to enrollment.
  • Ability to give informed consent and understand the tasks involved.
  • Age over 18 years.

Exclusion Criteria:

  • Hemorrhagic Stroke
  • Contraindications to TMS: history of seizure/epilepsy, pacemaker, other neurological disorders, brain surgery, metal implant/fragment in the head, pregnancy
  • Taking medications or substances that are known to affect PAS-induced plasticity within the past 2 months: selective serotonin reuptake inhibitors, dopamine, dopamine agonists, haloperidol, lithium, acetylcholinesterase inhibitors, beta-blockers, nimodipine, levetiracetam, ethosuximide, benzodiazepines, baclofen, nicotine
  • Peripheral neuropathy or history of nerve injury in the paretic upper limb.
  • Social and/or personal circumstances that interfere with ability to return for all study visits.

Sites / Locations

  • Burke Neurological Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

PAS true

PAS sham

Arm Description

Participants will receive paired associative stimulation therapy with a modulatory inter-stimulus interval.

Participants will receive paired associative stimulation therapy with a non modulatory inter-stimulus interval.

Outcomes

Primary Outcome Measures

Change in motor evoked potential amplitude
Assessment of corticospinal excitability

Secondary Outcome Measures

Full Information

First Posted
February 26, 2019
Last Updated
November 16, 2022
Sponsor
Burke Medical Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT03861806
Brief Title
Reliability of Paired Associative Stimulation-induced Neuroplasticity After Stroke
Acronym
PASS
Official Title
Reliability of Paired Associative Stimulation-induced Neuroplasticity After Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Terminated
Why Stopped
lack of funding
Study Start Date
April 17, 2019 (Actual)
Primary Completion Date
September 12, 2022 (Actual)
Study Completion Date
September 12, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Burke Medical Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Paired associative stimulation (PAS) is a non-invasive stimulation method which is known to modulate corticospinal excitability through mechanisms related to long-term potentiation and long-term depression. The purpose of this study is to determine the reliability of individual subject's response (i.e., change in corticospinal excitability) to PAS in patients with chronic stroke (>6 months) with upper limb motor deficits.
Detailed Description
One of the assumptions in stroke rehabilitation is that motor training will lead to motor re-learning and persistent improvements through mechanisms involving neuroplasticity, defined as the ability of the brain to change its structure and function in response to injury, activity, or change in environment. A way to measure a patient's capacity for neuroplasticity may be useful in guiding selection of patients for rehabilitative interventions, or to assess the effect of pharmacological agents on neuroplasticity which may aid in augmenting motor recovery. One method to assess neuroplasticity non-invasively in humans through the use of paired associative stimulation (PAS). PAS is a form of non-invasive stimulation that modulates corticospinal excitability through mechanisms related to long-term potentiation (LTP) and long-term depression (LTD). In PAS, repetitive pairing of peripheral nerve stimulation with a transcranial magnetic stimulation (TMS) pulse over the contralateral motor cortex will increase or decrease corticospinal excitability, depending on the timing between the two stimuli. In healthy subjects and patients with stroke, PAS has successfully been used to facilitate corticospinal excitability as a means to enhance motor performance. In this study, we plan to use PAS as an assay of corticospinal plasticity rather than as a therapeutic intervention in patients with chronic motor deficits (>6 months) due to ischemic stroke. There is large interindividual variability in individuals' responses to PAS, which may be useful in examining its relationship to motor learning, but the reliability of the measure will need to be assessed prior to using this measure to make inferences about a subject's general capacity to learn motor tasks. The reliability of the response to PAS and its relationship to clinical factors such as stroke severity, has not been well studied in patients with stroke. Results from a preliminary experiment suggest that stroke patients who have a robust response to facilitatory PAS on their unaffected hemisphere have more severe motor deficits than those who do not have a significant response to PAS.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
We plan a randomized crossover study of sham and true PAS.
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
15 (Actual)

8. Arms, Groups, and Interventions

Arm Title
PAS true
Arm Type
Experimental
Arm Description
Participants will receive paired associative stimulation therapy with a modulatory inter-stimulus interval.
Arm Title
PAS sham
Arm Type
Sham Comparator
Arm Description
Participants will receive paired associative stimulation therapy with a non modulatory inter-stimulus interval.
Intervention Type
Behavioral
Intervention Name(s)
PAS true
Intervention Description
Participants will receive paired associative stimulation (transcranial magnetic stimulation and peripheral nerve stimulation) with an inter-stimulus interval length known to modulate corticospinal excitability.
Intervention Type
Behavioral
Intervention Name(s)
PAS sham
Intervention Description
Participants will receive paired associative stimulation (transcranial magnetic stimulation and peripheral nerve stimulation) with an inter-stimulus interval length known to not modulate corticospinal excitability.
Primary Outcome Measure Information:
Title
Change in motor evoked potential amplitude
Description
Assessment of corticospinal excitability
Time Frame
Baseline, up to 30 min Post PAS

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Unilateral ischemic stroke with residual arm weakness (Fugl-Meyer Upper Limb < 60) more than 6 months prior to enrollment. Ability to give informed consent and understand the tasks involved. Age over 18 years. Exclusion Criteria: Hemorrhagic Stroke Contraindications to TMS: history of seizure/epilepsy, pacemaker, other neurological disorders, brain surgery, metal implant/fragment in the head, pregnancy Taking medications or substances that are known to affect PAS-induced plasticity within the past 2 months: selective serotonin reuptake inhibitors, dopamine, dopamine agonists, haloperidol, lithium, acetylcholinesterase inhibitors, beta-blockers, nimodipine, levetiracetam, ethosuximide, benzodiazepines, baclofen, nicotine Peripheral neuropathy or history of nerve injury in the paretic upper limb. Social and/or personal circumstances that interfere with ability to return for all study visits.
Facility Information:
Facility Name
Burke Neurological Institute
City
White Plains
State/Province
New York
ZIP/Postal Code
10605
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Reliability of Paired Associative Stimulation-induced Neuroplasticity After Stroke

We'll reach out to this number within 24 hrs